CSI Market
Sign In | Register

Genmab A (GMAB) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access GMAB quarterly Cash Flow →
The cash flow figures below highlight longer-term patterns in how Genmab A manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income1,204.00
Depreciation & amortization55.00
Amortization of Other Assets16.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss32.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments-3.00
Financial Instruments and Foreign Currency Transaction5.00
Adjustments For Finance Income-408.00
Adjustments For Finance Costs269.00
Adjustments For Sharebased Payments128.00
Adjustments For Decrease Increase In Trade And Other Receivables-166.00
Adjustments For Decrease Increase In Inventories-9.00
Adjustments For Increase Decrease In Other Liabilities400.00
Cash Flow From Used In Operating Activities Before Financial Items1,521.00
Adjustments For Interest On Lease Payments-5.00
Adjustments For Income Tax Expense-460.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities-
Purchase Of Other Longterm Assets Classified As Investing Activities-7,215.00
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities18.00
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities5,712.00
Discontinued operations0.00
Net Cash flow from Operating Activities1,186.00
Investing Activities
Capital Expenditures37.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Purchase Of Investments Other Than Investments Accounted For Using Equity Method991.00
Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method2,622.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans18.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-7,237.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-5,643.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net4,789.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4,789.00
Effect of exchange rate on cash flow3.00
Discontinued operations1,715.00
Free Cash Flow1,223.00
Total Cash Flow1,380.00
4 historic quarters locked

Sign in to unlock the full Genmab A cash flow history.

Sign In Create Free Account

About Genmab A s Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001434265-26-000014

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License